EFFICACY AND SAFETY OF USTEKINUMAB THROUGH WEEK 16 IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS RANDOMIZED TO USTEKINUMAB: RESULTS FROM THE UNIFI INDUCTION TRIAL

被引：0
|
作者：
Danese, Silvio
Sands, Bruce E.
O'Brien, Christopher D.
Zhang, Hongyan
Johanns, Jewel
Sloan, Sheldon
Izanec, James L.
Szapary, Philippe
Marano, Colleen W.
Leong, Rupert W.
Rowbotham, David
Targan, Stephan R.
Van Assche, Gert A.
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1739
引用
收藏
页码：S1106 / S1106
页数：1
相关论文
共 50 条
  • [21] Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 4 Years: Final Results of the UNIFI Long-Term Maintenance Study
    Afif, Waqqas
    Arasaradnam, Ramesh P.
    Abreu, Maria T.
    Danese, Silvio
    Sandborn, William J.
    Miao, Ye
    Zhang, Hongyan
    Panaccione, Remo
    Hisamatsu, Tadakazu
    Scherl, Ellen J.
    Leong, Rupert W.
    Rowbotham, David S.
    Peyrin-Biroulet, Laurent
    Sands, Bruce E.
    Marano, Colleen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (05): : 910 - 921
  • [22] Efficacy and Safety of Maintenance Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension
    Abreu, Maria T.
    Rowbotham, David S.
    Danese, Silvio
    Sandborn, William J.
    Miao, Ye
    Zhang, Hongyan
    Tikhonov, Ilia
    Panaccione, Remo
    Hisamatsu, Tadakazu
    Scherl, Ellen J.
    Leong, Rupert W.
    Arasaradnam, Ramesh P.
    Afif, Waqqas
    Peyrin-Biroulet, Laurent
    Sands, Bruce E.
    Marano, Colleen
    JOURNAL OF CROHNS & COLITIS, 2022, 16 (08): : 1222 - 1234
  • [23] Efficacy of Ustekinumab for Ulcerative Colitis in Patients Through 3 Years: UNIFI Long-term Extension
    Abreu, Maria T.
    Rowbotham, David S.
    Danese, Silvio
    Sandborn, William J.
    Miao, Ye
    Zhang, Hongyan
    Panaccione, Remo
    Hisamatsu, Tadakazu
    Scherl, Ellen
    Leong, Rupert
    Arasaradnam, Ramesh
    Afif, Waqqas
    Peyrin-Biroulet, Laurent
    Sands, Bruce E.
    Marano, Colleen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S315 - S315
  • [24] Pharmacokinetics and Exposure-Response Relationships of Ustekinumab in Patients With Ulcerative Colitis: Results From the UNIFI Induction and Maintenance Studies
    Adedokun, Omoniyi J.
    Xu, Zhenhua
    Marano, Colleen
    O'Brien, Christopher
    Szapary, Philippe
    Zhang, Hongyan
    Johanns, Jewel
    Leong, Rupert W. L.
    Hisamatsu, Tadakazu
    Van Assche, Gert
    Danese, Silvio
    Abreu, Maria T.
    Sands, Bruce E.
    Sandborn, William J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S481 - S482
  • [25] Efficacy and safety of ustekinumab for Ulcerative Colitis through 4 years in Asian patients: Final results from the sub-population of UNIFI long-term extension
    Hisamatsu, T.
    Kim, H. J.
    Motoya, S.
    Suzuki, Y.
    Ohnishi, Y.
    Marano, C.
    Imai, Y.
    Saadoun, C.
    Zhuo, J.
    Kawamura, S.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 566 - 568
  • [26] Efficacy of ustekinumab for ulcerative colitis through 2 years: Results of the UNIFI maintenance study and long-term extension
    Panaccione, R.
    Sandborn, W. J.
    Sands, B. E.
    Marano, C.
    O'Brien, C. D.
    Zhang, H.
    Johanns, J.
    Zhou, Y.
    Peyrin-Biroulet, L.
    Hisamatsu, T.
    Danese, S.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S049 - S049
  • [27] EFFICACY OF USTEKINUMAB FOR ULCERATIVE COLITIS THROUGH 2 YEARS: RESULTS OF THE UNIFI MAINTENANCE STUDY AND LONG-TERM EXTENSION
    Sandborn, William J.
    Sands, Bruce E.
    Panaccione, Remo
    Marano, Colleen W.
    O'Brien, Christopher D.
    Zhang, Hongyan
    Johanns, Jewel
    Zhou, Yiying
    Peyrin-Biroulet, Laurent
    Hisamatsu, Tadakazu
    Danese, Silvio
    GASTROENTEROLOGY, 2020, 158 (06) : S1186 - S1186
  • [28] MOLECULAR RESPONSE TO USTEKINUMAB IN MODERATE-TO-SEVERE ULCERATIVE COLITIS BY SERUM PROTEIN AND BIOPSY GENE EXPRESSION ANALYSIS: RESULTS FROM THE UNIFI PHASE 3 INDUCTION STUDY
    Li, Katherine
    Yang, Feifei
    Hayden, Karen
    Strawn, David
    Wadman, Eric
    Bhagat, Sunita
    Marano, Colleen W.
    Friedman, Joshua R.
    GASTROENTEROLOGY, 2019, 156 (06) : S1104 - S1105
  • [29] Molecular response to ustekinumab in moderate-to-severe ulcerative colitis by serum protein and biopsy gene expression analysis: Results from the UNIFI Phase 3 induction study
    Li, K.
    Yang, F.
    Hayden, K.
    Strawn, D.
    Wadman, E.
    Bhagat, S.
    Marano, C.
    Friedman, J. R.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S8 - S9
  • [30] Efficacy and safety of intravenous ustekinumab re-induction therapy in Crohn's disease patients with secondary loss of response to ustekinumab maintenance therapy: Week 16 results from the POWER trial
    Schreiber, S. W.
    Lee, S.
    Van der Woude, C. J.
    Marin-Jimenez, I.
    Wolf, D.
    Schnoy, E.
    Salzberg, B.
    Busse, C.
    Nazar, M.
    Langholff, W.
    Borghorst, S.
    Gasink, C.
    Baker, T.
    Godwin, B.
    Feagan, B.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 564 - 564
12345